Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Apr-11 5:00 PM View:  | Sanofi-Aventis 10% Owner | Genzyme Corp. (GENZ) | 08-Apr-11 | Private Purchase | 20,681,300 | $59.96 | $1,240,050,048.00 | 9% 232.88M to 253.56M | |
| 08-Apr-11 5:00 PM View: | Sanofi-Aventis 10% Owner | Genzyme Corp. (GENZ) | 07-Apr-11 | Purchase | 44,891,200 | -- | -- | 24% 187.99M to 232.88M | |
| 08-Apr-11 5:00 PM View: | Sanofi-Aventis 10% Owner | Genzyme Corp. (GENZ) | 06-Apr-11 | Purchase | 3,947,680 | -- | -- | 2% 184.04M to 187.99M | |
| 06-Apr-11 12:56 PM View: | Syron Richard F/ca Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 2,375 | $74.00 | $175,750.00 | (32%) 7.39K to 5.01K | (3%) |
| 06-Apr-11 11:44 AM View: | Csimma Zoltan A SrVP,Chief Human Resources Off | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 12,980 | $74.00 | $960,520.00 | (100%) 12.98K to 0 | (3%) |
| 06-Apr-11 2:06 PM View: | McGillicudy Cornelius III Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 5,000 | $74.00 | $370,000.00 | (100%) 5.0K to 0 | (3%) |
| 06-Apr-11 2:03 PM View: | Dzau Victor J Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 2,550 | $74.00 | $188,700.00 | (100%) 2.55K to 0 | (3%) |
| 06-Apr-11 12:56 PM View: | Syron Richard F/ca Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 2,375 | -- | -- | 47% 5.01K to 7.39K | |
| 06-Apr-11 11:45 AM View: | Smith Alan E Sr VP,Chief Scientific Officer | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 221 | $74.00 | $16,354.00 | (100%) 0.22K to 0 | (3%) |
| 06-Apr-11 11:44 AM View: | Meeker David P ExecVP,Chief Operating Officer | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 1,326 | $74.00 | $98,124.00 | (100%) 1.33K to 0 | (3%) |
| 06-Apr-11 11:49 AM View: | Wyzga Michael S Executive VP and CFO | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 29,250 | $74.00 | $2,164,500.00 | (51%) 57.35K to 28.11K | (3%) |
| 06-Apr-11 11:44 AM View: | Moscicki Richard A Sr VP,Chief Medical Officer | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 15,762 | $74.00 | $1,166,390.00 | (43%) 36.81K to 21.05K | (3%) |
| 06-Apr-11 11:49 AM View: | Wirth Peter Exec VP,Legal & Corporate Dev. | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 15,660 | $74.00 | $1,158,840.00 | (99%) 15.81K to 0.15K | (3%) |
| 06-Apr-11 11:49 AM View: | Termeer Henri A Chmn, President and CEO Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 22,510 | $74.00 | $1,665,740.00 | (100%) 22.51K to 0 | (3%) |
| 06-Apr-11 12:56 PM View: | Carpenter Robert J Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 31,825 | $74.00 | $2,355,050.00 | (100%) 31.82K to 0 | (3%) |
| 06-Apr-11 12:56 PM View: | Ende Eric J Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 2,375 | $74.00 | $175,750.00 | (100%) 2.38K to 0 | (3%) |
| 06-Apr-11 2:03 PM View: | Dzau Victor J Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 6,319 | $75.25 | $475,529.00 | (46%) 13.87K to 7.55K | (1%) |
| 06-Apr-11 11:44 AM View: | Moscicki Richard A Sr VP,Chief Medical Officer | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 218 | $74.00 | $16,132.00 | (100%) 0.22K to 0 | (3%) |
| 06-Apr-11 12:14 PM View: | Bertolini Robert J Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 2,375 | $74.00 | $175,750.00 | (50%) 4.75K to 2.38K | (3%) |
| 06-Apr-11 12:49 PM View: | Fenton Dennis M Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 2,375 | -- | -- | 669% 0.35K to 2.73K | |
| 06-Apr-11 8:24 PM View: | Berthiaume Douglas A Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 11,381 | -- | -- | 16% 71.16K to 82.54K | |
| 06-Apr-11 12:49 PM View: | Boudreaux Gail Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 2,375 | $74.00 | $175,750.00 | (32%) 7.38K to 5.0K | (3%) |
| 06-Apr-11 11:44 AM View: | Csimma Zoltan A SrVP,Chief Human Resources Off | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 5,765 | $74.00 | $426,610.00 | (31%) 18.75K to 12.98K | (3%) |
| 06-Apr-11 12:14 PM View: | Bertolini Robert J Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 2,375 | $74.00 | $175,750.00 | (100%) 2.38K to 0 | (3%) |
| 06-Apr-11 8:24 PM View: | Berthiaume Douglas A Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 71,158 | $74.00 | $5,265,690.00 | (100%) 71.16K to 0 | (3%) |
| 06-Apr-11 12:49 PM View: | Boudreaux Gail Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 2,375 | -- | -- | 47% 5.0K to 7.38K | |
| 06-Apr-11 11:44 AM View: | Geraghty James A Senior Vice President | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 4,845 | $74.00 | $358,530.00 | (98%) 4.96K to 0.11K | (3%) |
| 06-Apr-11 12:59 PM View: | Whitworth Ralph V Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 2,375 | $74.00 | $175,750.00 | (< 1%) 10.61M to 10.61M | (3%) |
| 06-Apr-11 12:01 PM View: | Amello Jason CorpContrllr,ChiefAccntOfficer | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 2,084 | $74.00 | $154,216.00 | (100%) 2.08K to 0 | (3%) |
| 06-Apr-11 12:56 PM View: | Carpenter Robert J Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 2,375 | -- | -- | 7% 31.82K to 34.2K | |
| 06-Apr-11 11:44 AM View: | Csimma Zoltan A SrVP,Chief Human Resources Off | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 5,640 | -- | -- | 43% 13.11K to 18.75K | |
| 06-Apr-11 12:59 PM View: | Whitworth Ralph V Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 10,606,200 | $74.00 | $784,862,016.00 | (100%) 10.61M to 2.38K | (3%) |
| 06-Apr-11 2:03 PM View: | Cooney Charles L Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 8,387 | $74.00 | $620,638.00 | (70%) 12.01K to 3.62K | (3%) |
| 06-Apr-11 11:49 AM View: | Smith Sandford D Exe VP,President Int'l Group | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 14,500 | $74.00 | $1,073,000.00 | (41%) 35.17K to 20.67K | (3%) |
| 06-Apr-11 12:56 PM View: | Syron Richard F/ca Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 5,011 | $74.00 | $370,814.00 | (100%) 5.01K to 0 | (3%) |
| 06-Apr-11 11:49 AM View: | Wirth Peter Exec VP,Legal & Corporate Dev. | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 29,250 | $74.00 | $2,164,500.00 | (65%) 45.06K to 15.81K | (3%) |
| 06-Apr-11 11:49 AM View: | Smith Sandford D Exe VP,President Int'l Group | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 14,500 | -- | -- | 70% 20.67K to 35.17K | |
| 06-Apr-11 2:03 PM View: | Cooney Charles L Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 6,352 | $75.26 | $478,057.00 | (35%) 18.36K to 12.01K | (1%) |
| 06-Apr-11 11:49 AM View: | Wyzga Michael S Executive VP and CFO | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 29,250 | -- | -- | 104% 28.11K to 57.35K | |
| 06-Apr-11 11:44 AM View: | Moscicki Richard A Sr VP,Chief Medical Officer | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 15,762 | -- | -- | 75% 21.05K to 36.81K | |
| 06-Apr-11 11:49 AM View: | Wirth Peter Exec VP,Legal & Corporate Dev. | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 148 | $74.00 | $10,952.00 | (100%) 0.15K to 0 | (3%) |
| 06-Apr-11 11:49 AM View: | Smith Sandford D Exe VP,President Int'l Group | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 20,671 | $74.00 | $1,529,650.00 | (100%) 20.67K to 0 | (3%) |
| 06-Apr-11 12:56 PM View: | Burakoff Steven Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 2,375 | $74.00 | $175,750.00 | (100%) 2.38K to 0 | (3%) |
| 06-Apr-11 8:24 PM View: | Berthiaume Douglas A Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 11,381 | $75.59 | $860,285.00 | (14%) 82.54K to 71.16K | (< 1%) |
| 06-Apr-11 12:56 PM View: | Ende Eric J Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 2,375 | -- | -- | 100% 0 to 2.38K | |
| 06-Apr-11 11:49 AM View: | Wyzga Michael S Executive VP and CFO | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 24,475 | $74.00 | $1,811,150.00 | (87%) 28.11K to 3.63K | (3%) |
| 06-Apr-11 11:45 AM View: | Smith Alan E Sr VP,Chief Scientific Officer | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 7,815 | $74.00 | $578,310.00 | (17%) 45.66K to 37.84K | (3%) |
| 06-Apr-11 11:44 AM View: | Desrosier Thomas Sr VP, General Counsel | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 5,738 | $74.00 | $424,612.00 | (47%) 12.24K to 6.5K | (3%) |
| 06-Apr-11 12:49 PM View: | Fenton Dennis M Director | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 355 | $74.00 | $26,270.00 | (100%) 0.35K to 0 | (3%) |
| 06-Apr-11 11:44 AM View: | Canute Scott A Executive VP | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 25,000 | $74.00 | $1,850,000.00 | (100%) 25.0K to 0 | (3%) |
